Skip to content
  • Home
    • Journal information
    • Editorial board
    • Operations manual
    • Editorial policies
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • TOC Alert
    • Current issue
  • Information
    • Editorial & Peer Review
    • Ethical policies
    • Funding
    • Complaints and appeals
    • Open access and licensing
    • Authors
    • Sponsorship
    • Contact
  • Publish
    • Instructions to authors
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • ES
  • EN
0,00 € 0 Cart
  • TOC Alert

Author: creacionmx

HIV and aging, biological mechanisms, and therapies: What do we know?

HIV and liver disease

A cure for HIV on the horizon

Antiretroviral therapy and weight gain in naive HIV-1 infected patient: a narrative review

Research progress on HIV-1 immune escape mechanisms

News from CROI 2022 – caveats using antiretrovirals as HIV prophylaxis

Humanized mouse models for preclinical evaluation of HIV cure strategies

Unexplained hepatitis in children after lifting COVID-19 pandemic restrictions

Is SARS-CoV-2 the only cause of long-COVID?

Less hepatic decompensation events but rising liver cancer in hepatitis B patients on long-term nucleos(t)ide therapy

← previous
Next →
PERMANYER
  • permanyer@permanyer.com
  • www.permanyer.com

Mallorca, 310
08037 Barcelona (España)

Arquímedes, 190 – Colonia Polanco
Delegación Miguel Hidalgo
11560 Ciudad de México (México)

RECURRING LINKS
  • Current Issue
  • Ahead of Print
  • Archive
  • Online submission
  • Contact
CLOCKSS is a dak archive that ensures the long-term survival of web-based scholary publications, governed by and for its stakeholders.

This journal adheres to the principles established by the Committee on Publication Ethics

Visitors: 45,285

  • Copyright 2025
  • Legal Notice
  • Permissions & Reprints
  • Data Protection Policy
  • Ethics Code
  • Conflicts of Interest